CBLN1 and metabolic syndrome: Cer(d18:1/16:0) resulted higher in female patients (1 ± 0.4 vs. 0.9 ± 0.2 μM in males, p < 0.05; Figure 4), in patients with dyslipidemia (1 ± 0.3 vs. 0.9 ± 0.3 μM in males, p < 0.05), and increased with aging (Table 2).